Prophylactic Erythropoietin for Neuroprotection in Very Preterm Infants: A Meta-Analysis Update

A meta-analysis update of randomized controlled trials investigating recombinant human erythropoietin suggests improved neurodevelopmental outcome in preterm infants. There was substantial heterogeneity, which could be ascribed to a single trial. Exclusion of this trial featuring a high risk of bias...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Hendrik S., Reibel, Nora J., Bührer, Christoph, Dame, Christof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173165/
https://www.ncbi.nlm.nih.gov/pubmed/34095027
http://dx.doi.org/10.3389/fped.2021.657228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173165/
https://www.ncbi.nlm.nih.gov/pubmed/34095027
http://dx.doi.org/10.3389/fped.2021.657228

Ejemplares similares